Silence Therapeutics (SLN) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.09
-0.05
-0.01
0.02

Details

Expected EPS
-0.050972922
Actual EPS
-0.064691235
Surprise EPS
-0.01
Surprise Percent
-26.91%

Description

⁨Silence Therapeutics⁩ (⁦SLN⁩) has reported earnings of ⁦-0.064691235⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts